The US Bankruptcy Court granted an order for the extension of the exclusivity periods for Timber Pharmaceuticals, Inc. on April 4, 2024. As per the order, the debtor?s exclusivity period to file its plan and to solicit votes on its plan, have been extended by 90 days i.e., up to June 17, 2024, and August 13, 2024, respectively.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | +100.00% | -83.33% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-83.33% | 617 | |
+0.81% | 42.86B | |
+12.53% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+6.46% | 25.15B | |
-23.58% | 18.63B | |
+29.19% | 12.37B | |
-3.20% | 11.92B | |
+7.06% | 11.21B |
- Stock Market
- Equities
- TMBRQ Stock
- News Trex Wind-down, Inc.
- First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.